- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| home:othertreatments:sample_page [11.21.2018] – [Further reading] sallieq | home:othertreatments:sample_page [09.14.2022] (current) – external edit 127.0.0.1 | ||
|---|---|---|---|
| Line 7: | Line 7: | ||
| === Place to practise page construction === | === Place to practise page construction === | ||
| - | [[http:// | + | [[https:// |
| Line 13: | Line 13: | ||
| === WIP === | === WIP === | ||
| - | // | + | // |
| Line 60: | Line 60: | ||
| insert | insert | ||
| - | //**authors et al.// (({{pubmed> | + | //**authors et al.// (({{pmid> |
| </ | </ | ||
| Line 94: | Line 94: | ||
| ===== Further reading ===== | ===== Further reading ===== | ||
| - | possible comprehensive tags resources_for_physicians resource Starting_the_Marshall_Protocol disease diseases symptoms tests MP supplements Non-MP_therapies Other_medication Food_and_drink Lifestyle_modifications Special_issues social_and_psychological science pathogenesis alternate_models | + | possible comprehensive tags: resources_for_physicians resource Starting_the_Marshall_Protocol disease diseases symptoms tests MP supplements Non-MP_therapies Other_medication Food_and_drink Lifestyle_modifications Special_issues social_and_psychological science pathogenesis alternate_models |
| | | ||
| Line 100: | Line 100: | ||
| tags {{tag> | tags {{tag> | ||
| + | < | ||
| ===== Notes and comments ===== | ===== Notes and comments ===== | ||
| Line 108: | Line 109: | ||
| =====References===== | =====References===== | ||
| + | </ | ||
home/othertreatments/sample_page.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.